Specialty / Expertise

Melanoma and Renal Cancer

Research Interests

Immunotherapy, Activated lymphocytes and cytokines

Current Research Projects

Research Staff

Training

Dr. Thompson received his MD from University of Alabama, Birmingham, AL. He completed his Internal Medicine Residency at the University of Washington, Seattle, WA. He was a Post-Doctoral Fellow in Oncology at the University of Washington, Seattle, WA.

Selected Publications:

Thompson JA, Curti BD, Redman BG, Bhatia S, Weber JS, Agarwala SS, Sievers EL, Hughes SD, Devries TA, Hausman DF. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. J Clin Oncol 2008 Mar 17; [Epub ahead of print]

Thompson JA, Fisher RI, Lebland M, Forman SJ, Press OW, Unger JM, Nademanee AP, Stiff PJ, Petersdorf SH, Fefer A. Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem cell transplantation followed by randomization to therapy with Interleukin-2 versus observation for patients with non-Hodkin's lymphoma: results of a phase III randomized trial by the Southwest Oncology Group (SWOG 9438). Blood 2008 Feb 6; [Epub ahead of print]

Green D, Thompson JA, Montgomery, RB. Oncologic Emergencies, in Rippe and Irwin's Intensive Care Medicine, Sixth edition, Lippincott Williams & Wilkens, Philadelphia, 2006.

Dummer R, Garbe C, Thompson JA, Eggermont AM, Koo K, Maier T, Bergstrom B. Ramdomized dose-escalation study evaluating perinterferon alfa-2a in patients with metastatic malignant melanoma. J Clin Oncol 2006 24(7):1188-1194.

Tykodi SS, Warren EH, Thompson JA, Riddell SR, Childs RW, Otterud BE, Leppert MG, Storb R, Sandmaier BM. Allogeneic hematopoietic cell transplantation for renal cell carcinoma after nonmyeloablative conditioning: Toxicity, clinical response, and immunological response to minor histocompatibility antigens. Clin Cancer Res 2004 10:7799-7811.

Balch CM, Buzaid AC, Soon S-J, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. An evidence-based staging system for cutaneous melanoma. CA A Journal for Clinicians 2004 54:131-149.